Friday, 27 November 2020

FDA Approves Y-mAbs’ DANYELZA® (naxitamab-gqgk) for the Treatment of Neuroblastoma



source https://www.pharmatutor.org/pharma-news/2020/fda-approves-y-mabs-danyelza-naxitamab-gqgk-for-the-treatment-of-neuroblastoma
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Career for Pharmacy and Biotech at National Agri-Food and Biomanufacturing Institute

Positions: Junior Research Fellow (JRF) (One) Master’s Degree from a recognized University/Institute in M.Sc. Chemistry - Organic / Physical...